The American Cancer Society estimates that approximately 16,600 new cases of myeloma are diagnosed each year in the United States. Bone pain is the most common early symptom of myeloma. Most patients feel pain in their back or ribs, but it can occur in any bone. The pain is usually made worse by movement.

Patients fatigue more easily and often feel weak. They may also have a pale complexion from anemia which is a common medical problem for patients with myeloma and may contribute to the fatigue. If the disease progresses, the concentration of normal cells in the blood may also decrease. Headaches, bruising, nose bleeding, gastrointestinal bleeding, and tingling or numbness in extremities are all symptoms of myeloma.

Patients may have repeated infections because antibodies to invading viruses, bacteria or other disease agents are not made efficiently of in adequate amounts. Urinary tract, bronchial, lung, skin, or other sites of infection may be the first sign of the disease. In addition, recurrent infections may complicate the course of the disease.

Discoveries have linked certain viruses to cancer growth. The hepatitis B virus is related to liver cancer. Women who develop cervical cancer have had a human papilloma virus (HPV) infection but not all women with HPV infection will develop cervical cancer. Stomach ulcers are likely caused by Helicobactor pylori, or H. pylori a bacteria and the ulcers can grow into cancer. Viruses attack cells in the body and once these cells are corrupted they begin to grow uncontrollably, eventually leading to cancer.

With these discoveries leads us to the knowledge that protecting the immune system in the body and keeping viruses at bay, is important in preventing cancer. Viruses enter the body through everyday activities like eating, breathing and sexual activity. Eating well, exercising and avoiding alcohol and cigarettes are good ways to keep your body's natural defenses functioning at their best. Staying protected with condoms during sexual intercourse helps protect you from sexually transmitted viruses and diseases. Learning healthy life style habits is the beginning of keeping cancer at bay. Focusing on nutrition, exercise, body weight, keeping toxins out of our bodies and our home environment ,and lowering stress will all help boost the immune system.

While the effectiveness of a seaweed extract acting as a potent inhibitor of human papilloma viruses, HPV, that can lead in some cases to cervical cancer, has not been tested in any human clinical trials -- in the lab it has impressed the National Cancer Institute researchers who have been studying it.

According to researchers, carrageenan extracted from marine red algae (seaweed) showed a thousand-fold greater potency compared with other inhibitors they have tested in halting HPV.

Dr. John Schiller, senior investigator at the National Cancer Institute, who was involved in the development of the HPV vaccine, made the carrageenan discovery.

Schiller cautions that the results do not prove that carrageenan will work as a practical HPV topical microbicide. However, the positive results in the lab, together with the fact that carrageenan-based over-the-counter products are already available -- make carrageenan look even more promising to researchers in blocking the sexual transmission of HPV.

The new cervical cancer vaccine is effective for about 70 percent of the HPV viruses that can cause cervical cancer. It is also an expensive vaccine that might prove cost prohibitive for low-income women in economically distressed countries. The researchers think, if carrageenan proves as effective in human clinical trails as it has in the lab, the inexpensive carrageenan could be a significant benefit in the prevention of HPV.

One researcher, Dr. Connie Trimble, an HPV researcher at Johns Hopkins University, feels so positive about the recent advancements and discoveries in relation to cervical cancer that she said, "With all the potential tools now, we could really start to think about the end of cervical cancer. Between the vaccines and some of the prophylactics -- wouldn't that be a medical success story!"

According to the Cancer Research of UK, one study estimates  more than 1.8 million new cases of virus-associated cancer are diagnosed world-wide each year. The group believes that progress can be made to prevent additional cases of cancer by focusing on vaccines to battle the viruses. While very few individuals with viruses actually go on to develop cancer, the possibility of preventing that percentage, estimated to be at about 25 percent world wide, is enticing to many researchers. In particular, cervical cancer research has seen some exciting advancement this year with the use of the vaccine that helps curb infection from the human papilloma virus (HPV).  Other cancers that have been linked to viruses are: stomach, liver, nasopharyngeal carcinoma (nasal passages), lymphomas and leukemia.